Stocks
Simulations Plus IncSLP
NASDAQTechnologyApplication Software$18.50
Price as of · delayed, not real-time
A provider of simulation software and consulting services for the pharmaceutical and biotechnology industries, modeling drug absorption, distribution, metabolism, and excretion. Its platforms support drug development from preclinical through clinical stages, and the company also offers data analytics and regulatory support. Investors track it as a specialized play on the digitization of drug R&D and the adoption of model-informed drug development.
52W Range: $11.09-$21.01
Congressional Interest in Simulations Plus Inc (SLP)
No congressional trades have been disclosed for Simulations Plus Inc (SLP) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading SLP?
No congressional trades found for this stock.